Evidence map›Paper›PMID 42477177›Full record

ArticleJournal of neurology2026

The Queen Square cognitive assessment screen (Q-CAS): normative data and validation in acute stroke.

Edgar Chan, Maria Del Rocio Hidalgo Mas, Adrian So, Robert Simister, David J Werring, Parashkev Nachev, Lisa Cipolotti

Abstract readValidation Study
In one paragraph

Article in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Edgar ChanDepartment of Neuropsychology, National Hospital for Neurology & Neurosurgery, UCLH, Queen Square, Box 37, London, WC1N 3BG, UK. Edgar.chan1@nhs.net.ORCID http://orcid.org/0000-0003-2312-683X
Maria Del Rocio Hidalgo MasUniversity College London, London, UK.
Adrian SoUniversity College London, London, UK.
Robert SimisterUCL Stroke Research Centre, Department of Translational Neuroscience and Stroke, UCL Queen Square Institute of Neurology, London, UK.
David J WerringUCL Stroke Research Centre, Department of Translational Neuroscience and Stroke, UCL Queen Square Institute of Neurology, London, UK.
Parashkev NachevDepartment of Translational Neuroscience and Stroke, UCL Queen Square Institute of Neurology, London, UK.
Lisa CipolottiDepartment of Neuropsychology, National Hospital for Neurology & Neurosurgery, UCLH, Queen Square, Box 37, London, WC1N 3BG, UK.

Funding

UCLH Biomedical Research Centre F218
6 · The paper itself

Abstract

backgroundAccurate and comprehensive assessment of cognition after stroke is crucial for diagnosis and rehabilitation. However, detailed assessment by a Neuropsychologist is often not feasible or practical. Although many screening tools exist, none fulfill three critical criteria: 1) assess all stroke-relevant domains, 2) consider demographic variables of gender, age, education level, and whether English is a first or second language, and 3) is brief and can be easily administered.

methodsThe Q-CAS was developed by adapting well-validated neuropsychological tests. Cognitive domains include verbal/spatial memory, naming, perception, attention, executive functions, processing speed, and mood. We administered the Q-CAS to healthy individuals and patients with acute mild-to-moderate stroke, and examined aspects of reliability, convergent and divergent validity, and diagnostic accuracy against reference-standard neuropsychological testing.

results648 healthy individuals and 150 patients with acute stroke were assessed. The mean completion time was 9 min for healthy individuals and 15 min for stroke patients. All Q-CAS subtests demonstrated clinically acceptable convergent and divergent validity against neuropsychological tests. ROC curve analyses showed good discrimination for all cognitive domains and were comparable for left- and right-hemisphere lesions. Using a novel simple scoring method which incorporates demographic variables, executive function, speed, and memory showed the best sensitivity (> 0.8), whereas perception and attention showed the best specificity (> 0.8).

conclusionThe Q-CAS is a brief cognitive screening tool assessing six core cognitive domains and mood. Validated in acute stroke, it demonstrates good discrimination across domains and offers a practical first-line approach that mitigates limitations of existing tools while balancing brevity and thoroughness.

Indexed as

Cognition DisordersNeuropsychological TestsStrokeAdultAgedAged, 80 and overExecutive FunctionFemaleHumansMaleMiddle AgedProcessing SpeedReproducibility of ResultsCognitionExecutive functionsMoodNeuropsychologyScreening

Identifiers

PMID42477177
PMCPMC13385056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.